SYGNIS Appoints Dr. Miguel-Antonio Viribay as Vice President Sales and Marketing
- Dr. Viribay adds more than 16 years of international experience in molecular biology and biotechnology markets
- Strong focus on boosting international sales, mainly in Europe and the US
Madrid, Spain and Heidelberg, Germany, April 22nd, 2015 – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that Dr. Miguel-Antonio Viribay has joined SYGNIS and will assume responsibility for the further development, implementation and execution of sales and marketing strategies as Vice President Sales and Marketing.
Dr. Viribay has over 16 years of successful international experience in the biotech industry. He held executive positions in the sales and marketing departments of leading American companies operating in Southern Europe, such as Life Technologies, Agilent or, more recently, Thermo Fisher. All these companies specialize in products for molecular biology and next generation sequencing, priority areas also for SYGNIS. Mr. Viribay holds a PhD in Molecular Genetics.
In his newly created position as Vice President Sales and Marketing, Dr. Viribay will be responsible for deepening the marketing approach, based on direct sale of SYGNIS products as well as on agreements with SYGNIS’ distribution partners worldwide, developing new business and sales strategies, and promoting online sales in order to boost international sales, especially in the European and US markets.
“We are very much looking forward to welcoming Dr. Viribay to SYGNIS”, Pilar de la Huerta, CEO and CFO of SYGNIS commented. “Dr. Viribay’s extensive experience in world-wide marketing and sales in the biotechnology industry combined with his scientific excellence in molecular science will support and further enhance SYGNIS position as a leading provider of innovative products and technologies for DNA amplification and sequencing in growth markets, especially in Europe and the US. Now that we have expanded our scope of business and are selling our own products, Dr. Viribay will play a key role as we continue to pursue our growth strategy and position our products for long- term success.”
“I am very pleased to join SYGNIS at this exciting point in its journey,” Dr. Miguel-Antonio Viribay added. “With the launch of its second product line in just seven months the company paved the ground for future success and I am very much looking forward to contribute to its next phase of growth and joining this proven and dynamic management team.”
For further information please contact:
Pilar de la Huerta
Phone: +34 91 192 36 50
MC Services AG
Phone: +49 89 210228 30